Encryption and secure hosting
Protect information in processing and hosting with enterprise-grade safeguards.
Privacy and security are foundational when Life Sciences teams use AI Agents to work with clinical and regulatory information.
Data privacy is a core principle at Narrativa. Your enterprise data remains under your control: we do not store or share it, or use it to train our models. Information is processed securely and made accessible only to authorized users or teams within your organization.
That foundation matters when AI Agents help pharmaceutical and biotech teams transform clinical, safety, and regulatory information into review-ready content.
Our platform is built to protect confidentiality and integrity while supporting the privacy, security, and GxP requirements of regulated teams.
Protect information in processing and hosting with enterprise-grade safeguards.
Use strict access controls and role-based permissions to limit access to authorized people.
Support alignment with global privacy regulations, including GDPR, and regulated-workflow expectations.
Narrativa operates under a zero data retention policy for all customer content processed through our AI platform, chatbot, and services.
Prompts, documents, and other inputs you submit are processed to generate a response and are not stored after the request is completed.
Generated content is delivered to you and automatically discarded from our systems.
We do not use customer data, inputs, or outputs to train AI models, and we prohibit our third-party model providers from doing the same under zero-data-retention agreements.
The only retained records are minimal operational logs (e.g., for security and quality monitoring), which exclude your document content and are deleted on a rolling 30-day cycle.
You can exercise your right to erasure at any time. Any retained operational logs are also deleted on request, without waiting for the 30-day cycle.
For on-premise and private-cloud deployments, no data leaves your infrastructure, and retention is governed entirely by your own policies.
Where personal data is involved (for example, the email address you provide in a form), the retention rules in our Privacy Policy apply.
Narrativa has successfully completed a SOC 2 Type 2 audit for its Life Sciences platform, validating that rigorous, independently verified security controls are in place to protect your clinical and regulatory data.
Audited by Sensiba for the period July 1 to September 30, 2026, covering our Software as a Service system.
The attestation covers the Security, Availability, and Confidentiality criteria — the controls that matter for regulated Life Sciences work.
The full SOC 2 Type 2 report and attestation letter are available upon formal request under a mutually signed NDA. Learn more in our Trust Center.
Personal and health information can require heightened confidentiality. In Life Sciences, privacy controls help teams use AI Agents for regulated work while protecting sensitive clinical documents and data.
Explore Redaction Scout for clinical document anonymization, and Medical Authoring Companion for AI-assisted clinical and regulatory authoring.
Collect only what is needed and use information for clear, lawful purposes.
Keep information accurate and avoid retaining it longer than necessary.
Use explicit consent and risk assessments, including Data Protection Impact Assessments where required.
Combine encryption, anonymization, access controls, and incident-response planning to protect information.
Data-protection frameworks such as GDPR set practical principles for handling personal information responsibly.
Be clear about how information is processed and respect the rights of the people it concerns.
Use data for defined purposes and collect no more than the workflow requires.
Maintain accurate records and set appropriate limits on data retention.
Protect information with appropriate safeguards and assess risks in sensitive processing.
See how Narrativa approaches regulated AI in Compliance, or talk with our team about privacy and security in your Life Sciences workflows.
Talk to our team ↗At Narrativa, we ensure your data is protected with state-of-the-art encryption, secure hosting, and compliance with global privacy standards.
Data privacy is not just a policy for Narrativa—it is a core principle. Your enterprise data stays fully under your control. We do not store, share, or use your data to train our models. All information is processed securely and remains accessible only to authorized users or teams within your organization.
Our platform is built with strict adherence to privacy, security, and GxP compliance standards. We go beyond basic legal requirements by providing an enterprise-grade agentic AI solution designed to meet the highest expectations for confidentiality and regulatory alignment.
With Narrativa, you can automate content creation with confidence, knowing your proprietary data is protected at every step.
Data handling
Narrativa treats your proprietary data with the utmost care. Our platform is built to uphold the confidentiality and integrity of your information through rigorous security and privacy practices.
Data protection
We employ enterprise-grade safeguards, including encryption, strict access controls, and role-based permissions, to ensure your data remains protected at all times.
Privacy assurance
Narrativa complies with global data privacy regulations, including GDPR, and maintains a strong commitment to regulatory alignment. Our platform is designed to meet the highest standards of privacy, giving you confidence in every interaction.
What is data sensitivity?
Data sensitivity refers to the degree of confidentiality that certain information requires. Examples of sensitive data include any information that has the potential to identify a person, including personal addresses or medical conditions. The General Data Protection Regulation (GDPR) defines sensitive data as a “special category” that includes racial information, political opinions, personal beliefs, trade union membership, genetic data, biometric data, health data, and sexual orientation.
Protecting sensitive data is critical for both legal and strategic reasons. Regulations such as GDPR, the UK Data Protection Act, and the US PSQIA impose strict requirements, with non compliance leading to significant financial penalties. Beyond regulation, strong data protection enhances a company’s reputation, builds customer trust, and reduces exposure to cyberattacks. Implementing safeguards like encryption, anonymization, and incident response plans not only protects users but also limits legal liability in the event of a breach and helps organizations respond quickly without major operational disruption.
Data protection frameworks, particularly the GDPR, establish clear principles for handling personal information responsibly. These include ensuring lawful and transparent processing, limiting data collection to specific purposes, minimizing the amount of data collected, maintaining accuracy, restricting storage duration, and guaranteeing security. For sensitive data, explicit user consent is required, along with risk assessments such as Data Protection Impact Assessments. In complex sectors like pharmaceuticals, where large volumes of sensitive data are processed, companies often rely on specialized providers like Narrativa to automate anonymization and maintain consistent compliance while reducing operational burden.
Key points:
– Industries like healthcare and government handle higher volumes of sensitive data
– Protecting data helps avoid legal penalties, reputational damage, and cyber threats
– Security measures include encryption, anonymization, and incident response planning
– GDPR principles guide lawful, minimal, accurate, and secure data processing
– Explicit user consent and risk assessments are required for sensitive data
– Specialized solutions like Narrativa help automate compliance and data protection processes
The Wall Street Journal, one of the most influential newspapers in the world, is now using Narrativa’s Natural Language Generation (NLG) services to automate its news. Alyssa Zeisler, R&D editor at The Wall Street Journal, recently revealed on Medium how they use our artificial intelligence system and the benefits this brings to their digital strategy.
Alyssa Zeisler